Pfizer and Allergan have announced a “merger” where Pfizer is essentially acquiring Allergan so it can perform a tax inversion to relocate to Ireland (where Allergan is based). This is the second time Allergan has been acquired since we purchased it back in June, 2013, with the first being the takeover by Actavis last fall. Then…
Resolution to the Allergan Deal
We finally have a resolution to the takeover of Allergan and boy did we benefit as shareholders. After a long battle against Bill Ackman and Valeant Pharmaceuticals that began with a takeover offer in April, Allergan has decided to accept a “friendly” takeover offer from Actavis for $219/share valued at $66 billion. I was initially…
And the Takeovers Continue
It was announced last night that activist investor Bill Ackman of Pershing Square Capital Management and Valeant Pharmaceuticals were teaming up in an attempt to takeover Allergan. Allergan, which is one of our larger growth holdings, was up 6% yesterday and is currently up another 15% today, as of this writing. I love a takeover…